Navigation Links
Research Brings New Hope to Multiple Sclerosis Patients
Date:2/18/2009

Aurora St. Luke's Medical Center Discovers Way to Fight Rare, but Deadly, Side Effect from Drug.

MILWAUKEE, Feb. 18 /PRNewswire/ -- Researchers at Aurora St. Luke's Medical Center have developed a technique that counteracts an unusual, but serious, side effect from natalizumab (Tysabri(R)), a drug that fights multiple sclerosis (MS).

The side effect is a brain virus called progressive multifocal leukoencephalopathy (PML).

"This virus looks like a multiple sclerosis relapse," Dr. Bhupendra Khatri says. "It rapidly destroys the white matter of the brain. Now we know exactly how to respond if this virus emerges."

The response is a series of plasma exchanges that filter the drug out of the blood stream, allowing the immune system to recover and fight the virus.

Multiple sclerosis is a disease where the body's immune system attacks the protective sheath surrounding the nerves. Natalizumab suppresses the immune system to slow or halt the progression of the disease. However, if the patient contracts PML, the immune system is not strong enough to combat the infection, so the drug needs to be removed from the body quickly.

Dr. Khatri, medical director of Aurora's Regional MS Center is lead author of the study published in the Feb. 3 issue of Neurology, the official publication of the American Academy of Neurology.

In the study 12 multiple sclerosis patients on natalizumab underwent three plasma exchange sessions over a five-day or an eight-day period. By replacing the drug-infused plasma with clean fluid, Dr. Khatri and his team were able to get 92 percent of the drug out of patients' bodies over a span of eight days instead of the 12 weeks it would take with no treatment.

Debra Goodwin, a clinical research nurse who worked on the study and a multiple sclerosis patient herself, says the discovery gives new hope to those with
'/>"/>

SOURCE Aurora St. Luke's Medical Center
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Study calls for increased research in flu transmission to prepare for pandemic flu outbreak
2. Research increases possibilities of personalizing treatment of infant osteosarcoma
3. Two Scientists Honored with MetLife Foundation Awards for Medical Research in Alzheimers Disease
4. The Canadian Foundation for Global Health Announces a Research and Development Partnership with Medizone International, Inc.
5. Apple's iPod Touch Joins the iPhone as a Stuttering Therapy Tool At Hollins Communications Research Institute
6. Rice Universitys Baker Institute experts available to discuss stem cell research, recommendations
7. eResearchTechnology, Inc. to Announce Fourth Quarter and Full Year 2008 Results on February 26, 2009
8. National Pharmaceutical Council on Economic Stimulus Package: Comparative Effectiveness Research Funding Should Target Improvements in Quality of Patient Care
9. OHSU vaccine research targets HIV in the slower, early stage of infection
10. American Association for Cancer Research lauds Senator Arlen Specter
11. In flurry of studies, researcher details role of apples in inhibiting breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2015)... National Sales Solutions , ... and supply chain management for consumer packaged goods ... its award winning solutions for thinning-damaged hair to ... specifically created to combat thinning-damaged hair. Known ... to marrying science with nature to create the ...
(Date:2/28/2015)... 28, 2015 A case management conference ... that have been filed by law firms including Bernstein ... in March, the Firm notes. , According to ... in the federal litigation will meet on March 13, ... prescription therapy treatments designed to raise levels of the ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 On Thursday, February ... Make It Easy For Scammers To Steal Your Data , ... get their hands on a DIY phishing kit, or any ... also touched on another important point about how everyone’s cyber ... are often implemented, “like compromising legitimate content management systems or ...
(Date:2/28/2015)... 2015 Developers of FCPX plugins ... overlay plugin for Final Cut Pro X entitled FCPX Overlay ... Chromatic gives users total control over 6k lens dirt overlays ... Pixel Film Studios. “FCPX Overlay Chromatic was professionally designed to ... interface.” , FCPX Overlay Chromatic Grunge 6K is a resourceful ...
(Date:2/28/2015)... Aliso Viejo, California (PRWEB) February 28, 2015 ... the release of TransFold Volume 2. A fully customizable ... Pro X. , “TransFold Volume 2 gives users total ... users,” said Christina Austin, CEO of Pixel Film Studios. ... Cut Pro X editor.” , TransFold Volume 2 from ...
Breaking Medicine News(10 mins):Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 2Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 3Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 2Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 3Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 4Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 2Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 3Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 4Health News:Pixel Film Studios released a new overlay plugin entitled FCPX Overlay Chromatic Grunge 6K exclusively for Final Cut Pro X users 2Health News:Announcing a New TransFold Transition Pack from Pixel Film Studios for Final Cut Pro X Professionals 2
... take place on March 10 in Los Angeles, ... Feb. 8 U.S. Health Disparities,Forum organizer Luis ... on Feb. 12 at 1 p.m. EST to ... and presenters will discuss new opportunities for,preventive care ...
... MBF Healthcare,Acquisition Corp. (AMEX: MBH ), a ... it will host an investor,conference call on Friday, ... to,discuss the recently announced signing of a definitive ... (along with its,subsidiaries, "CHS"). Hosting the call from ...
... Improved ... Quality of Sleep ... (TSX: DDS;,NASDAQ: DDSS) today announced that its recently completed North ... trazodone (study 04ACL3-001) achieved statistical,significance for the primary efficacy endpoint ...
... Offering Period, BASEL, Switzerland, Feb. 8 ... its wholly-owned,subsidiary Rocket Acquisition Corporation has accepted for ... offer for all outstanding,shares of common stock of ... at,$89.50 per share in cash., As of ...
... health and ... fitness cruise, RANCHO SANTA MARGARITA, Calif., Feb. 7 ... a 5-day Adventure Boot,Camp Fitness Cruise to the Mexican Riviera porting April 28, ... well as those experiencing the boot camp for the first time., Attendees ...
... research showed it greatly boosted pregnancy chances , , THURSDAY, ... fertilization can increase their chances of becoming pregnant by ... a preliminary study suggests. , , About 10 percent ... many opt for in vitro fertilization, in which a ...
Cached Medicine News:Health News:U.S. Health Disparities Forum to Hold Media Briefing 2Health News:MBF Healthcare Acquisition Corp. to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings, Inc. 2Health News:MBF Healthcare Acquisition Corp. to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings, Inc. 3Health News:MBF Healthcare Acquisition Corp. to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings, Inc. 4Health News:Labopharm Reports Positive Results for Phase III Study on Once-daily Trazodone 2Health News:Labopharm Reports Positive Results for Phase III Study on Once-daily Trazodone 3Health News:Roche Purchases Shares in Tender Offer for Ventana 2Health News:Roche Purchases Shares in Tender Offer for Ventana 3Health News:Roche Purchases Shares in Tender Offer for Ventana 4Health News:QueensLander Tours Presents an Adventure Boot Camp Cruise with John Spencer Ellis from Bravo's The Real Housewives of Orange County 2Health News:Acupuncture May Aid In Vitro Fertilization 2Health News:Acupuncture May Aid In Vitro Fertilization 3
(Date:2/27/2015)... 2015  Following a bipartisan vote in the ... 284, the Medicare DMEPOS Competitive Bidding Improvement Act ... (AAHomecare) released a statement praising the Committee,s work ... legislation. "Today,s mark-up of the Competitive ... Means Committee is a critical step forward for ...
(Date:2/27/2015)... Feb. 27, 2015 Isis Pharmaceuticals, Inc. (Nasdaq: ... both its pro forma net operating loss (NOL) guidance ... strong financial position.  Isis, significantly improved financial results were ... million in payments the Company received from its partners.  ... was a nearly 60% improvement over its 2013 NOL ...
(Date:2/27/2015)... Mass. , Feb. 27, 2015  Boston Scientific ... participate in the Barclays 2015 Annual Healthcare Conference on ... Dan Brennan , executive vice president ... vice president, Investor Relations, will participate in a 25-minute ... host analyst at approximately 1:05 p.m. ET. Following a ...
Breaking Medicine Technology:Bidding Fix Takes Major Step Forward After Bipartisan Vote of House Ways and Means Committee 2Isis Reports Financial Results and Highlights for 2014 2Isis Reports Financial Results and Highlights for 2014 3Isis Reports Financial Results and Highlights for 2014 4Isis Reports Financial Results and Highlights for 2014 5Isis Reports Financial Results and Highlights for 2014 6Isis Reports Financial Results and Highlights for 2014 7Isis Reports Financial Results and Highlights for 2014 8Isis Reports Financial Results and Highlights for 2014 9Isis Reports Financial Results and Highlights for 2014 10Isis Reports Financial Results and Highlights for 2014 11Isis Reports Financial Results and Highlights for 2014 12Isis Reports Financial Results and Highlights for 2014 13Isis Reports Financial Results and Highlights for 2014 14Isis Reports Financial Results and Highlights for 2014 15Isis Reports Financial Results and Highlights for 2014 16Isis Reports Financial Results and Highlights for 2014 17Boston Scientific to Participate in the Barclays 2015 Annual Healthcare Conference 2
... 9 BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX ) today ... the Company,s Board of Directors. Dr. Sanders brings to ... and professor of medicine. , "We are pleased ... Zola P. Horovitz, Ph.D., Chairman of the Board of BioCryst ...
... , LONDON, Dec. 9 ... $1 billion in the European Union (EU), which includes total ... anticholinergics used for disease symptom relief. With the introduction of ... guidelines that call for using dopamine agonists as first-line therapy, ...
Cached Medicine Technology:BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 2BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 3BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 4Drug Candidates in Pipeline Offer Potential for Parkinson's Disease Therapeutics Market, Says Frost & Sullivan 2Drug Candidates in Pipeline Offer Potential for Parkinson's Disease Therapeutics Market, Says Frost & Sullivan 3
For the quantitative in vitro determination of Lipoprotein (a) in human serum or plasma....
Immunoturbidimetric assay for the quantitative in vitro determination of Lipoprotein (a) in human serum or plasma...
For the quantitative in vitro determination of Digitoxin in human serum....
For the quantitative in vitro determination of Valproic Acid in human serum...
Medicine Products: